当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2007年第36期
编号:11529514
氯吡格雷对急性冠脉综合征的抗感染作用观察(2)
http://www.100md.com 2008年2月24日 依仁科 邹 玲 宋耀锋 董 志
第1页

    参见附件(222KB,2页)。

     [2]Ridker PM.High-sensitivity C-reactive protein: potential adjunct for global risk assessmentin the primary prevention of cardiovascular disease[J]. Circulation,2001,103:1813-1818.

    [3] UskiyamaS Lane TM, Moore KL , et al. Structurat and functional characterization of momomeric soluble P-selection and comparison with wem brane P-selection[J]. J Biol Chem,1993,268:15229.

    [4]Atalar E, Aytemir K, Haznedaroglu I, et al. Increased plasma levels of soluble selectins in pations with unstable angina[J].Int J Cardiol,2001,78:69-73.

    [5]Chew DP, Bhatt DL, Robbins MA, et al. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reaction protein[J].Am J Cardiol,2001,88:672-674.

    [6]Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human exvivo in vitro model[J]. Clin Pharmacol Ther,2002,71:176-185.

    (收稿日期:2007-08-27)

    “本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”

您现在查看是摘要介绍页,详见PDF附件(222KB,2页)